Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors
- 26 September 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (22) , 3983-3987
- https://doi.org/10.1016/j.bmcl.2003.08.056
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesityEmerging Therapeutic Targets, 1999
- Differential expression of cGMP‐inhibited cyclic nucleotide phosphodiesterases in human hepatoma cell linesFEBS Letters, 1996
- Characterization of Two Recombinant PDE3 (cGMP-Inhibited Cyclic Nucleotide Phosphodiesterase) Isoforms, RcGIP1 and HcGIP2, Expressed in NIH 3006 Murine Fibroblasts and Sf9 Insect CellsBiochemistry, 1996
- An enantioselective synthesis of SK&F 93505, a key intermediate for preparing cardiotonic agentsThe Journal of Organic Chemistry, 1991
- Nonsteroidal cardiotonics. 3. New 4,5-dihydro-6-(1H-indol-5-yl)pyridazin-3(2H)-ones and related compounds with positive inotropic activitiesJournal of Medicinal Chemistry, 1990
- 1,4-Bis(3-oxo-2,3-dihydropyridazin-6-yl)benzene analogs: potent phosphodiesterase inhibitors and inodilatorsJournal of Medicinal Chemistry, 1990
- Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activityJournal of Medicinal Chemistry, 1987
- Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogs of imazodan (CI-914)Journal of Medicinal Chemistry, 1987
- A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug SelectivityJournal of Medicinal Chemistry, 1985
- Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. III. N-Cyclohexyl-N-(2-hydroxyethyl)-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide and related compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983